Quality Judgments, Cost Concerns Must Be Separated In Peer Review

Peer Review Few discussions arouse as much emotion in the scientific community as the controversy over peer review. As the number of unfunded grants started to rise in the early 1990s, so did complaints about unfair criticisms by reviewers. Many whose applications were unsuccessful claimed that the decisions often were based on reviewers' comments that were inaccurate, irrelevant, or glibly disparaging. While critics of the peer-review system called for reform, its defenders countered that th

Written byOleg Jardetzky
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Peer Review Few discussions arouse as much emotion in the scientific community as the controversy over peer review. As the number of unfunded grants started to rise in the early 1990s, so did complaints about unfair criticisms by reviewers. Many whose applications were unsuccessful claimed that the decisions often were based on reviewers' comments that were inaccurate, irrelevant, or glibly disparaging.

While critics of the peer-review system called for reform, its defenders countered that the only problem with the system is a lack of funding to support meritorious research. In reality, the shortage of funding and the fairness of the review process are two separate problems that must be addressed.

The need for reform of the existing system has been perceived for some time. At a 1994 meeting called to discuss administrative changes in the National Institutes of Health's peer-review process (D.M. Barnes, Journal of NIH Research, 6[10]:10, 1994), fairness ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies